Clinical Trials Browser

Phase 1 × Carcinoma, Non-Small-Cell Lung × apatinib × Clear all

NCT03050411 2017-02-10

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung